USNA compared with GCO: revenue, margins and what each company keeps, and the suppliers and customers both name

USNAUsana Health Sciences Inc

Mkt capRevenueRevenue

GCOGenesco Inc

Mkt capRevenueRevenue

Compare

USNAUsana Health Sciences Inc

GCOGenesco Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

USNA

1 of 3at or beyond implied

Reportimpliedrealized× implied

Nov 4 '26—▼−3.63%—

Aug 5 '26±19.6%▼−34.20%×1.74

May 6 '26±21.5%▲+3.89%×0.18

Feb 18 '26±18.9%▼−8.03%×0.42

GCO

1 of 4at or beyond implied

Reportimpliedrealized× implied

Sep 3 '26±13.2%▲+2.74%×0.20

May 29 '26±14.3%▲+5.47%×0.38

= impliedUSNA realized, solidGCO realized, hatchedOne scale, both sides: full bar = 35%× = |realized| ÷ impliedSource: market data

Mar 6 '26

±15.3%

▲+1.57%

×0.10

Dec 4 '25±11.1%▼−30.84%×2.77

USNAUsana Health Sciences Inc

13.60▼−1.88%· post 13.50

Mkt cap$251.8MRevenue$223MQ2 FY26Revenue$925MFY25

GCOGenesco Inc

36.72▼−0.67%· post 36.72

ClosedNov 6 '26

Mkt cap$390.3MRevenue$530MQ2 FY27Revenue$2.4BFY26

Compare

ClosedNov 6 '26

USNAUsana Health Sciences Inc

GCOGenesco Inc

13.60▼−1.88%post 13.50

Price

36.72▼−0.67%post 36.72

$251.8M

Mkt cap

$390.3M

Q2 FY26$223M

Revenue

$530MQ2 FY27

FY25$925M

Revenue

$2.4BFY26

USNA13.60▼−1.88%vsGCO36.72▼−0.67%ClosedNov 6 '26